XERIJECT

Serial Number 98677676
730

Registration Progress

Application Filed
Aug 1, 2024
Under Examination
Jan 7, 2025
Approved for Publication
Nov 26, 2024
Published for Opposition
Nov 26, 2024
Registered

Attorney Assistance

Statement of Use Due - Extension 1 Granted
Due: Jan 07, 2026 176 days

Trademark Image

XERIJECT

Basic Information

Serial Number
98677676
Filing Date
August 1, 2024
Published for Opposition
November 26, 2024
Drawing Code
4

Status Summary

Current Status
Active
Status Code
730
Status Date
Jul 7, 2025
Application
Pending
Classes
005

Rights Holder

Xeris Pharmaceuticals, Inc.

03
Address
1375 W Fulton St Suite 1300
Chicago, IL 60607

Ownership History

Xeris Pharmaceuticals, Inc.

Original Applicant
03
Chicago, IL

Xeris Pharmaceuticals, Inc.

Owner at Publication
03
Chicago, IL

Legal Representation

Attorney
Tracy-Gene G. Durkin

USPTO Deadlines

Next Deadline
176 days remaining
Statement of Use Due - Extension 1 Granted
Due Date
January 07, 2026
Extension Available
Until January 07, 2026

Application History

12 events
Date Code Type Description Documents
Jul 8, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jul 7, 2025 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jul 7, 2025 EX1G S SOU EXTENSION 1 GRANTED Loading...
Jul 7, 2025 EXT1 S SOU EXTENSION 1 FILED Loading...
Jan 7, 2025 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Nov 26, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Nov 26, 2024 PUBO A PUBLISHED FOR OPPOSITION Loading...
Nov 20, 2024 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Nov 2, 2024 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Nov 2, 2024 DOCK D ASSIGNED TO EXAMINER Loading...
Aug 1, 2024 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Aug 1, 2024 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations for the treatment of diseases and conditions, namely, alimentary tract, metabolic, oncologic, autoimmune, and nervous system diseases and conditions; pharmaceutical preparations for the treatment of diseases and conditions, namely, anti-invectives to prevent or treat infections, vaccines, antineoplastic pharmaceutical preparations for the treatment of cancer, and immunomodulating pharmaceutical preparations for the treatment of immune system related diseases and disorders

Classification

International Classes
005